Search Within

Ellen Marlese Basu

  1. "Biostatistics Service"
Formats
  1. Meeting Abstract (12)
  2. Journal Article (11)
Groups
  1. Biostatistics Service (23)
  2. Epidemiology and Biostatistics (23)
  3. Neuroblastoma Service (23)
  4. Pediatrics, Department of (23)
  5. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (18)
  6. GSK Faculty (18)

More Groups

People
  1. Shakeel Modak (22)
  2. Brian Kushner (18)
  3. Nai-Kong Cheung (18)
  4. Audrey Mauguen (16)
  5. Stephen Roberts (16)
  6. Irene Cheung (8)

More People

Years
  1. 2025 (1)
  2. 2024 (3)
  3. 2023 (3)
  4. 2022 (2)
  5. 2021 (2)
  6. 2020 (2)

More Years

Publications
  1. Pediatric Blood and Cancer (7)
  2. Journal of Clinical Oncology (5)
  3. Cancer Research (2)
  4. Cancer (1)
  5. Clinical Cancer Research (1)
  6. JAMA Oncology (1)

More Publications

Publishers
  1. Wiley Periodicals, Inc (7)
  2. American Society of Clinical Oncology (5)
  3. American Association for Cancer Research (3)
  4. American Academy of Pediatrics (1)
  5. American Medical Association (1)
  6. Impact Journals (1)

More Publishers

Results (23)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Survival impact of anti-GD2 antibody response in a phase II ganglioside vaccine trial among patients with high-risk neuroblastoma with prior disease progression
    Journal Article

    Cheung, I. Y.; Cheung, N. K. V.; Modak, S.; Mauguen, A.; Feng, Y.; Basu, E.; Roberts, S. S.; Ragupathi, G.; Kushner, B. H.
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Survival impact of anti-GD2 antibody response - A phase II ganglioside vaccine trial in relapsed neuroblastoma
    Meeting Abstract

    Cheung, I. Y.; Cheung, N. K. V.; Modak, S.; Mauguen, A.; Basu, E.; Roberts, S. S.; Ragupathi, G.; Kushner, B. H.
    Cancer Research (2020)

    Fulltext@MSK | Save
  • High-dose naxitamab (humanized-3F8) plus stepped-up dosing of granulocyte-macrophage colony-stimulating factor (GM-CSF) for Resistant Osteomedullary Neuroblastoma: Major Responses and Outpatient Treatment in a Phase II Trial
    Meeting Abstract

    Kushner, B.; Modak, S.; Basu, E.; Roberts, S.; Mauguen, A.; Pandit-Taskar, N.; Cheung, N. K.
    Pediatric Blood and Cancer (2020)

    Fulltext@MSK | Save
  • High-dose naxitamab (humanized-3F8) PLUS stepped-up dosing of granulocyte-macrophage colony-stimulating factor for neuroblastoma: Outpatient treament low immunogenicity, and major responses in a phase II trial
    Meeting Abstract

    Kushner, B.; Modak, S.; Basu, E.; Roberts, S.; Mauguen, A.; Pandit-Taskar, N.; Cheung, N. K.
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save
  • High-dose naxitamab (humanized-3F8) plus stepped-up dosing of granulocyte-macrophage colony-stimulating factor for relapsed neuroblastoma resistant to salvage therapy: A phase II trial
    Meeting Abstract

    Kushner, B.; Modak, S.; Basu, E.; Roberts, S.; Mauguen, A.; Pandit-Taskar, N.; Cheung, N. K.
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save
  • High-dose naxitamab (humanized-3F8) plus stepped-up dosing of granulocyte-macrophage colony-stimulating factor for consolidating >= 2nd complete remission of high-risk neuroblastoma
    Meeting Abstract

    Kushner, B.; Modak, S.; Basu, E.; Roberts, S.; Mauguen, A.; Cheung, N. K.
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save
  • A curative approach to central nervous system metastases of neuroblastoma
    Meeting Abstract

    Kramer, K.; Kushner, B.; Modak, S.; Pandit-Taskar, N.; Mauguen, A.; Tomlinson, U.; Wolden, S.; Zanzonico, P.; Humm, J.; Haque, S.; more...
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save
  • Local anesthesia with general anesthesia for pediatric bone marrow procedures
    Journal Article

    Zarnegar-Lumley, S.; Lange, K. R.; Mathias, M. D.; Nakajima-Hatano, M.; Offer, K. M.; Ogu, U. O.; Ortiz, M. V.; Tan, K. S.; Kellick, M.; Modak, S.; more...
    Pediatrics (2019)

    Fulltext@MSK | Save
  • Adoptive immunotherapy with haploidentical natural killer cells and Anti-GD2 monoclonal antibody m3F8 for resistant neuroblastoma: Results of a phase I study
    Journal Article

    Modak, S.; Le Luduec, J. B.; Cheung, I. Y.; Goldman, D. A.; Ostrovnaya, I.; Doubrovina, E.; Basu, E.; Kushner, B. H.; Kramer, K.; Roberts, S. S.; more...
    OncoImmunology (2018)

    Fulltext@MSK | Save
  • Reppair trial: Reducing procedural pain and improving recovery of quality of life in pediatric neuroblastoma patients undergoing bone marrow procedures, a prospective, randomized, cross-over clinical trial
    Meeting Abstract

    Zarnegar, S.; Lange, K.; Mathias, M.; Nakajima-Hatano, M.; Offer, K.; Ogu, U.; Ortiz, M.; Tan, K. S.; Kellick, M.; Basu, E.; more...
    Pediatric Blood and Cancer (2018)

    Fulltext@MSK | Save